D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$667M |
| 2 |
NVIDIA
NVDA
|
+$584M |
| 3 |
ConocoPhillips
COP
|
+$432M |
| 4 |
Amazon
AMZN
|
+$418M |
| 5 |
Johnson & Johnson
JNJ
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$836M |
| 2 |
Meta Platforms (Facebook)
META
|
+$525M |
| 3 |
Apple
AAPL
|
+$453M |
| 4 |
CELG
Celgene Corp
CELG
|
+$349M |
| 5 |
Pfizer
PFE
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.58% |
| 2 | Consumer Discretionary | 13.65% |
| 3 | Healthcare | 12.98% |
| 4 | Industrials | 7.3% |
| 5 | Financials | 7.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
Agilysys
AGYS
$2.91B
| $921K | ﹤0.01% |
42,912
-37,137
| -46% | -$770K |
|
2677
CALL
Warner Bros
WBD
$63.4B
| $921K | ﹤0.01% |
30,000
| – | – |
|
2678
Ingles Markets
IMKTA
$1.67B
| $920K | ﹤0.01% |
29,566
-3,498
| -11% | -$103K |
|
2679
PUT
Invesco
IVZ
$13.3B
| $917K | ﹤0.01% |
44,800
-20,000
| -31% | -$415K |
|
2680
CALL
Ameriprise Financial
AMP
$47.6B
| $915K | ﹤0.01% |
6,300
-6,800
| -52% | -$983K |
|
2681
PUT
Kinsale Capital Group
KNSL
$8.24B
| $915K | ﹤0.01% |
+10,000
| New | +$799K |
|
2682
PUT
ProShares Ultra VIX Short-Term Futures ETF
UVXY
$238M
| $913K | ﹤0.01% |
12
| – | – |
|
2683
BGC Group
BGC
$5.65B
| $911K | ﹤0.01% |
174,037
-388,260
| -69% | -$2.01M |
|
2684
Mammoth Energy Services
TUSK
$131M
| $911K | ﹤0.01% |
132,384
+38,439
| +41% | +$488K |
|
2685
CALL
Vornado Realty Trust
VNO
$7.43B
| $910K | ﹤0.01% |
14,200
| – | – |
|
|
IOTS
2686
DELISTED
Adesto Technologies Corp
IOTS
| $905K | ﹤0.01% |
111,075
+84,127
| +312% | +$603K |
|
|
MDSO
2687
CALL
DELISTED
Medidata Solutions, Inc.
MDSO
| $905K | ﹤0.01% |
+10,000
| New | +$878K |
|
2688
Madrigal Pharmaceuticals
MDGL
$12.7B
| $904K | ﹤0.01% |
8,627
+5,747
| +200% | +$616K |
|
2689
New Mountain Finance
NMFC
$649M
| $902K | ﹤0.01% |
64,543
-24,556
| -28% | -$343K |
|
|
HAPN
2690
Happen Inc
HAPN
$2.16B
| $901K | ﹤0.01% |
54,985
+17,766
| +48% | +$280K |
|
2691
PUT
Edgewell Personal Care
EPC
$1.28B
| $900K | ﹤0.01% |
+33,400
| New | +$1.19M |
|
2692
Expro Ltd
XPRO
$1.78B
| $900K | ﹤0.01% |
27,469
-23,429
| -46% | -$847K |
|
|
ESV
2693
PUT
DELISTED
Ensco Rowan plc
ESV
| $899K | ﹤0.01% |
+105,400
| New | +$1.22M |
|
2694
Duluth Holdings
DLTH
$162M
| $898K | ﹤0.01% |
66,106
-6,398
| -9% | -$104K |
|
2695
PUT
Bunge Global
BG
$22.8B
| $897K | ﹤0.01% |
16,100
-30,000
| -65% | -$1.6M |
|
|
CZZ
2696
DELISTED
Cosan Limited
CZZ
| $896K | ﹤0.01% |
67,056
-1,419
| -2% | -$17.5K |
|
2697
Axsome Therapeutics
AXSM
$12.3B
| $895K | ﹤0.01% |
+34,756
| New | +$697K |
|
2698
PUT
BlackBerry
BB
$4.93B
| $895K | ﹤0.01% |
120,000
| – | – |
|
2699
Natera
NTRA
$37B
| $891K | ﹤0.01% |
32,309
-137,729
| -81% | -$3.04M |
|
2700
CALL
Everest Group
EG
$15.4B
| $890K | ﹤0.01% |
3,600
-9,900
| -73% | -$2.38M |
|
Similar funds
D.E. Shaw & Co's Q2 2019 Portfolio in Review
As of Q2 2019, D.E. Shaw & Co held 4,048 positions worth $80.2B, up 3.6% from $77.4B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.
D.E. Shaw & Co's Q2 2019 filing shows 499 new, 1,419 increased, 1,452 reduced and 416 closed positions. Its largest new stake was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M. The largest sale was Qualcomm, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- D.E. Shaw & Co's largest Q2 2019 buy was Zayo Group Holdings, Inc.: 5,926,898 shares worth $195M.
- D.E. Shaw & Co added most to Alibaba in Q2 2019, an estimated $667M increase.
- D.E. Shaw & Co's biggest Q2 2019 reduction was Qualcomm, cutting an estimated $836M.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q2 2019, selling an estimated $42.7M.
- D.E. Shaw & Co's ten largest holdings make up 9.8% of its $80.2B portfolio in Q2 2019.
- D.E. Shaw & Co opened 499 new positions and closed 416 in Q2 2019.
- D.E. Shaw & Co's portfolio value rose 3.6% quarter-over-quarter to $80.2B.
Based on D.E. Shaw & Co's 13F filing for Q2 2019, filed 14 Aug 2019.